Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Infectious Diseases

• Publication date

  2008-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/590212PMID 18598197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• APOBEC3G levels predict rates of progression to AIDS

  2007cited by this paper
• Cytidine Deaminases APOBEC3G and APOBEC3F Interact with Human Immunodeficiency Virus Type 1 Integrase and Inhibit Proviral DNA Formation

  2007cited by this paper
• Effect of Genetic Variants of CCR2 and CCL2 on the Natural History of HIV-1 Infection: CCL2-2518GG Is Overrepresented in a Cohort of Spanish HIV-1-Infected Subjects

  2007cited by this paper
• Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.

  2007cited by this paper
• Biochemical Differentiation of APOBEC3F and APOBEC3G Proteins Associated with HIV-1 Life Cycle*

  2007cited by this paper
• High expression of APOBEC3G in patients infected with hepatitis C virus

  2006cited by this paper
• Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti–HIV-1 activity

  2006cited by this paper
• Alpha Interferon Potently Enhances the Anti-Human Immunodeficiency Virus Type 1 Activity of APOBEC3G in Resting Primary CD4 T Cells

  2006cited by this paper
• Elevations in IL-10, TNF-α, and IFN-γfrom the Earliest Point of HIV Type 1 Infection

  2006cited by this paper
• Anti-viral protein APOBEC3G is induced by interferon-α stimulation in human hepatocytes

  2006cited by this paper
• Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation

  2006cited by this paper
• Polymorphism of RANTES Chemokine Gene Promoter Is Not Associated With Long-Term Nonprogressive HIV-1 Infection of More Than 16 Years

  2006cited by this paper
• STAT1-Independent Cell Type-Specific Regulation of Antiviral APOBEC3G by IFN-α1

  2006cited by this paper
• Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.

  2006cited by this paper
• APOBEC3F and APOBEC3G mRNA Levels Do Not Correlate with Human Immunodeficiency Virus Type 1 Plasma Viremia or CD4+ T-Cell Count

  2006cited by this paper
• Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection.

  2006cited by this paper
• Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes.

  2006cited by this paper
• APOBEC3G/CEM15 (hA3G) mRNA Levels Associate Inversely with Human Immunodeficiency Virus Viremia

  2005cited by this paper
• Spanish HIV-1-Infected Long-Term Nonprogressors of More Than 15 Years Have an Increased Frequency of the CX3CR1 249I Variant Allele

  2005cited by this paper
• Low Human Immunodeficiency Virus Envelope Diversity Correlates with Low In Vitro Replication Capacity and Predicts Spontaneous Control of Plasma Viremia after Treatment Interruptions

  2005cited by this paper
• Role of viral evolutionary rate in HIV-1 disease progression in a linked cohort

  2005cited by this paper
• The Retroviral Hypermutation Specificity of APOBEC3F and APOBEC3G Is Governed by the C-terminal DNA Cytosine Deaminase Domain*

  2005cited by this paper
• Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

  2005cited by this paper
• Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging

  2004cited by this paper
• Retroviral restriction by APOBEC proteins

  2004cited by this paper
• Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.

  2004cited by this paper
• APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.

  2004cited by this paper
• Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.

  2004cited by this paper
• Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication

  2004cited by this paper
• Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells

  2004cited by this paper
• Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

  2003cited by this paper
• The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

  2003cited by this paper
• Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

  2003cited by this paper
• HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

  2003cited by this paper
• Faculty Opinions recommendation of Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

  2002cited by this paper
• An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

  2002cited by this paper
• Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

  2002cited by this paper
• Human Immunodeficiency Virus Type 1 DNA Sequences Genetically Damaged by Hypermutation Are Often Abundant in Patient Peripheral Blood Mononuclear Cells and May Be Generated during Near-Simultaneous Infection and Activation of CD4+ T Cells

  2001cited by this paper
• HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

  1999influential reference
• Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV‐1 infection

  1998cited by this paper
• Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses

  1997cited by this paper
• Perspectives series: host/pathogen interactions. Dynamics of HIV-1 replication in vivo.

  1997cited by this paper
• Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.

  1996cited by this paper
• Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

  1996cited by this paper
• Viral dynamics in human immunodeficiency virus type 1 infection

  1995cited by this paper
• Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

  1995cited by this paper
• Natural history of HIV-1 cell-free viremia.

  1995cited by this paper
• Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal.

  1993cited by this paper
• Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection.

  1993cited by this paper
• Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in west African female prostitutes.

  1992cited by this paper
• Interferon-Alpha and Tumor Necrosis Factor-Alpha in Serum of Patients in Various Stages of HIV-1 Infection

  1991cited by this paper
• High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.

  1991cited by this paper

• APOBEC3G Role on HIV Infection in Africa: A Systematic Review

  2024cites this paper
• Anatomical and physiological aspects of the HIV infection pathogenesis in animal models

  2022influential citation
• The cytidine deaminase APOBEC3G drives cancer mutagenesis and clonal evolution in bladder cancer

  2022cites this paper
• Polymorphisms in the APOBEC3G gene of Chinese rhesus macaques affect resistance to ubiquitination and degradation mediated by HIV-2 Vif

  2019cites this paper
• USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication

  2019cites this paper
• APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz

  2018cites this paper
• APOBEC3G expression and HIV-1 infection in Burkina Faso

  2018cites this paper
• Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication.

  2017cites this paper
• STUDIES ON THE MECHANISMS OF ANTI-HIV-1 FUNCTIONS OF APOBEC3F AND APOBEC3G

  2017influential citation
• Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono‐ and co‐infected patients

  2016cites this paper
• APOBEC3 proteins can copackage and comutate HIV-1 genomes

  2016cites this paper
• Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4+ T‐cell activation and dendritic cell maturation

  2016cites this paper
• Restriction Factors in HIV-1 Disease Progression.

  2015cites this paper
• Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

  2014cites this paper
• Alteration of select gene expression patterns in individuals infected with HIV‐1

  2014influential citation
• Resistance to simian immunodeficiency virus low dose rectal challenge is associated with higher constitutive TRIM5α expression in PBMC

  2014cites this paper
• Lack of Association between Intact/Deletion Polymorphisms of the APOBEC3B Gene and HIV-1 Risk

  2014cites this paper
• AID and APOBECs span the gap between innate and adaptive immunity

  2014influential citation
• Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles.

  2014cites this paper
• Possible Footprints of APOBEC3F and/or Other APOBEC3 Deaminases, but Not APOBEC3G, on HIV-1 from Patients with Acute/Early and Chronic Infections

  2014cites this paper
• APOBECs and Their Role in Proviral DNA Synthesis

  2013cites this paper
• [Use and research of pigtailed macaques in nonhuman primate HIV/AIDS models].

  2013cites this paper
• Accessory Genes Confer a High Replication Rate to Virulent Feline Immunodeficiency Virus

  2013cites this paper
• Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches

  2013cites this paper
• The Role of Cytidine Deaminases on Innate Immune Responses against Human Viral Infections

  2013cites this paper
• APOBEC3G-Augmented Stem Cell Therapy to Modulate HIV Replication: A Computational Study

  2013cites this paper
• BIOCHEMICAL ANALYSIS OF HIV RESTRICTION FACTORS: SINGLE DOMAIN DEOXYCYTIDINE DEAMINASES APOBEC3A AND APOBEC3H

  2013influential citation
• Feline restriction factors to lentiviral replication

  2013cites this paper
• Expression Analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and Tetherin in a Senegalese Cohort of HIV-1-Exposed Seronegative Individuals

  2012cites this paper
• Running Loose or Getting Lost: How HIV-1 Counters and Capitalizes on APOBEC3-Induced Mutagenesis through Its Vif Protein

  2012cites this paper
• EVALUATION OF IMMUNE MECHANISMS INVOLVED IN THE LACK OF CD4 T CELL RECOVERY IN HIV-INFECTED PATIENTS NON RESPONDER TO ANTIRETROVIRAL THERAPY

  2012cites this paper
• “Wrapped Up” Vaccines in the Context of HIV-1 Immunotherapy

  2012influential citation
• APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans

  2012cites this paper
• APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo.

  2012influential citation
• Generation of Recombinant Antibodies against HIV Clade C Envelope

  2011cites this paper
• Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys

  2011influential citation
• Expression of APOBEC3G/3F and G-to-A Hypermutation Levels in HIV-1-Infected Children with Different Profiles of Disease Progression

  2011cites this paper
• A POSITIVELY SELECTED APOBEC3H HAPLOTYPE IS ASSOCIATED WITH NATURAL RESISTANCE TO HIV‐1 INFECTION

  2011cites this paper
• Noninfectious Retrovirus Particles Drive the Apobec3/Rfv3 Dependent Neutralizing Antibody Response

  2011cites this paper
• Dual role of host cell factors in HIV-1 replication: restriction and enhancement of the viral cycle.

  2010cites this paper
• The Associations of hA3G and hA3B mRNA Levels With HIV Disease Progression Among HIV-Infected Individuals of China

  2010cites this paper
• Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics

  2010cites this paper
• APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load

  2010cites this paper
• Identification of Two APOBEC3F Splice Variants Displaying HIV-1 Antiviral Activity and Contrasting Sensitivity to Vif*

  2010cites this paper
• Differences in APOBEC3G Expression in CD4+ T Helper Lymphocyte Subtypes Modulate HIV-1 Infectivity

  2009cites this paper
• High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity

  2009cites this paper
• Restriction of vif-competent HIV-1 by physiological levels of APOBEC3G in primary T-helper cells

  2009cites this paper
• HIV pathogenesis: 25 years of progress and persistent challenges

  2009cites this paper
• APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression

  2009cites this paper
• Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets

  2009cites this paper
• The discoveries of human papilloma viruses that cause cervical cancer and of human immunodeficiency virus

  2008cites this paper
• "Up-dating the monograph." [corrected] Cytolytic immune lymphocytes in the armamentarium of the human host.

  2008cites this paper